Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Public Offering [Member]	Common Stock [Member]	Common Stock [Member] Public Offering [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] Public Offering [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]
Balances at beginning at Dec. 31, 2021	$ 17,793		$ 5		$ 231,143			$ (213,355)
Balances at beginning (shares) at Dec. 31, 2021			5,324,287
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,530				2,530
Issuance of common stock in connection with vesting of restricted stock units (shares)			18,650
Tax withholding payments for net share-settled equity awards	(16)				(16)
Tax withholding payments for net share-settled equity awards (shares)			(3,683)
Sale of common stock, net of issuance costs	342	$ 9,327		$ 3	342	$ 9,324
Sale of common stock, net of issuance costs (shares)			104,773	2,666,667
Sale of pre-funded warrants in public offering, net of issuance costs	4,439				4,439
Exercise of common stock warrants (shares)			48,688
Net Income (Loss)	(24,067)							(24,067)
Balances at ending at Dec. 31, 2022	10,348		$ 8		247,762			(237,422)
Balances at end (shares) at Dec. 31, 2022			8,159,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,809				5,809
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	483		$ 1		482
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (shares)			510,241
Tax withholding payments for net share-settled equity awards (shares)			(128)
Sale of common stock and issuance of common stock warrants and pre-funded common stock warrants, net of issuance costs	137,857		$ 6		137,851
Sale of common stock and issuance of common stock warrants and pre-funded common stock warrants, net of issuance costs (shares)			7,047,397
Exercise of common stock warrants	41,998		$ 17		41,981
Exercise of common stock warrants (shares)			15,961,267
Net Income (Loss)	(38,988)							(38,988)
Balances at ending at Dec. 31, 2023	157,507		$ 32		433,885			(276,410)
Balances at end (shares) at Dec. 31, 2023			31,678,159
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	99,958				99,958
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units	1,316		$ 1		1,315
Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (shares)			1,125,054
Sale of common stock, net of issuance costs	148,955		$ 4		148,951
Sale of common stock, net of issuance costs (shares)			3,450,000
Exercise of common stock warrants and pre-funded common stock warrants	12,866		$ 9		12,857
Exercise of common stock warrants and pre-funded common stock warrants (shares)			9,450,598
Unrealized gain on marketable securities	361						$ 361
Net Income (Loss)	(175,850)							(175,850)
Balances at ending at Dec. 31, 2024	$ 245,113		$ 46		$ 696,966		$ 361	$ (452,260)
Balances at end (shares) at Dec. 31, 2024			45,703,811